Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Colgate bolsters trade programs

This article was originally published in The Tan Sheet

Executive Summary

The Colgate toothpaste marketer is increasing its emphasis on trade spending with "sharper" programs to win consumers at the shelf, while also working to strengthen its partnership programs with retailers, Colgate-Palmolive President and CEO Ian Cook says. Programs to engage the consumer could provide an edge over competitors, as between 50 percent to 70 percent of final purchase decisions are made in-store, the executive noted during the Barclays Capital Back-To-School Consumer Conference Sept. 7. "These in-store activities relate to trial for new products as we are doing with our Colgate Sensitive Pro-Relief," Cook said. In Poland, the company employs in-store representatives to explain the benefits of Pro-Relief. The firm announced in 2009 it would create an "emotional connection" with financially strapped consumers via shelf programs offering a clear value proposition (1"The Tan Sheet" Feb. 2, 2009)

You may also be interested in...

Colgate Jumps On Weak Ad Market To Reconnect With Consumers

Colgate-Palmolive is capitalizing on the slumping ad market, purchasing media at a lower cost and launching campaigns to strengthen its emotional connection with consumers, the firm reported during an analyst meeting Jan. 29

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts